Apyx Medical Corp
NASDAQ:APYX

Watchlist Manager
Apyx Medical Corp Logo
Apyx Medical Corp
NASDAQ:APYX
Watchlist
Price: 3.49 USD -5.93% Market Closed
Market Cap: 143.1m USD

Wall Street
Price Targets

APYX Price Targets Summary
Apyx Medical Corp

Wall Street analysts forecast APYX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for APYX is 5.87 USD with a low forecast of 4.04 USD and a high forecast of 8.4 USD.

Lowest
Price Target
4.04 USD
16% Upside
Average
Price Target
5.87 USD
68% Upside
Highest
Price Target
8.4 USD
141% Upside
Apyx Medical Corp Competitors:
Price Targets
SGHT
Sight Sciences Inc
5% Downside
228850
Rayence Co Ltd
39% Upside
LUCD
Lucid Diagnostics Inc
245% Upside
214150
Classys Inc
29% Upside
HOLX
Hologic Inc
3% Upside
FEMY
Femasys Inc
512% Upside
CMP
Compumedics Ltd
112% Upside
DIA
DiaSorin SpA
37% Upside

Revenue
Forecast

Revenue Estimate
Apyx Medical Corp

For the last 13 years the compound annual growth rate for Apyx Medical Corp's revenue is 5%. The projected CAGR for the next 4 years is 11%.

5%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Apyx Medical Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Apyx Medical Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-20%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is APYX's stock price target?
Price Target
5.87 USD

According to Wall Street analysts, the average 1-year price target for APYX is 5.87 USD with a low forecast of 4.04 USD and a high forecast of 8.4 USD.

What is Apyx Medical Corp's Revenue forecast?
Projected CAGR
11%

For the last 13 years the compound annual growth rate for Apyx Medical Corp's revenue is 5%. The projected CAGR for the next 4 years is 11%.

Back to Top